{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:42Z","timestamp":1786119162679,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1097\/rlu.0b013e318162de14","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T09:30:52Z","timestamp":1236245452000},"page":"198-200","source":"Crossref","is-referenced-by-count":1,"title":["Tc-99m Sestamibi Uptake Mimicking Parathyroid Adenoma in a Patient With Primary Hyperparathyroidism and Occult Multiple Myeloma"],"prefix":"10.1097","volume":"33","author":[{"given":"Fahmid U.","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew F.","family":"Scarsbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210204","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00003072-199203000-00003","article-title":"Clinical experience with Tc-99m MIBI imaging in patients with malignant tumours\u2014preliminary results and comparison with Tl-201.","volume":"17","author":"Aktolun","year":"1992","journal-title":"Clin Nucl Med"},{"key":"R2-11-20210204","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00003072-199805000-00004","article-title":"Tc-99m sestamibi imaging in the diagnostic assessment of patients with lymphoma: comparison with clinical and radiological evaluation.","volume":"23","author":"Maurea","year":"1998","journal-title":"Clin Nucl Med"},{"key":"R3-11-20210204","first-page":"596","article-title":"Potential of (99m)Tc-MIBI for detecting bone marrow metastases.","volume":"43","author":"Wakasugi","year":"2002","journal-title":"J Nucl Med"},{"key":"R4-11-20210204","first-page":"1001","article-title":"Technetium-99m-sestamibi uptake in myeloma.","volume":"37","author":"Adams","year":"1996","journal-title":"J Nucl Med"},{"key":"R5-11-20210204","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s002770100302","article-title":"Value of Tc-99m sestamibi scintigraphy in the detection of bone lesions in multiple myeloma: comparison with Tc-99m methylene diphosphonate.","volume":"80","author":"Alexandrakis","year":"2001","journal-title":"Ann Hematol"},{"key":"R6-11-20210204","first-page":"904","article-title":"Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma.","volume":"44","author":"Lorberboym","year":"2003","journal-title":"J Nucl Med"},{"key":"R7-11-20210204","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1055\/s-0038-1625193","article-title":"Combined transmission and (99m)Tc-sestamibi emission tomography for localization of mediastinal parathyroid glands.","volume":"42","author":"Kaczirek","year":"2003","journal-title":"Nuklearmedizin"},{"key":"R8-11-20210204","first-page":"211","article-title":"Hypercalcaemia as a symptom of primary hyperparathyroidism coexisting with multiple myeloma.","volume":"15","author":"Lenarcik","year":"2006","journal-title":"Adv Clin Exp Med"},{"key":"R9-11-20210204","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/01.rlu.0000170012.06271.76","article-title":"Hyperparathyroidism accompanying multiple myeloma.","volume":"30","author":"Patel","year":"2005","journal-title":"Clin Nucl Med"},{"key":"R10-11-20210204","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1507\/endocrj.44.105","article-title":"A case of primary hyperparathyroidism accompanying multiple myeloma.","volume":"44","author":"Otsuka","year":"1997","journal-title":"Endocr J"},{"key":"R11-11-20210204","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/(SICI)1096-8652(199810)59:2<168::AID-AJH11>3.0.CO;2-5","article-title":"Significance of parathyroid hormone-related protein as a factor stimulating bone resorption and causing hypercalcemia in myeloma.","volume":"59","author":"Tsujimura","year":"1998","journal-title":"Am J Hematol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003072-200803000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:43:07Z","timestamp":1786038187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003072-200803000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0b013e318162de14","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}